31.8 C
Vientiane
Sunday, September 7, 2025
spot_img
Home Blog Page 309

Fapon Biopharma Announces the enrollment of the First Patient in the Phase I Clinical Trial of FP008, A First-in-Class Immunotherapy for Solid Tumors

DONGGUAN, China, Aug 5, 2025 /PRNewswire/ — Fapon Biopharma, a biotech in developing therapeutic antibodies and fusion proteins, is delighted to announce the completion of the first patient enrollment  in China for its Phase I clinical trial of FP008 , a first-in-class immunotherapy for solid tumors, at Zhejiang Cancer Hospital. The patient has completed the Dose Limiting Toxicity (DLT) observation period with a favorable safety profile. The trial aims to evaluate the safety and tolerability of FP008 in patients with advanced solid tumors. 

As the latest next generation of immuno-oncology (IO) approach, FP008 is a novel anti-PD-1 × IL-10M fusion protein designed to overcome the limitations of current PD-1 inhibitors by using a proprietary IL-10 mutant that eliminates the toxicity associated with the wild-type protein. It represents a potential new therapeutic option for patients who are refractory to or relapsed from anti-PD-1/PD-L1 therapies. Preclinical studies demonstrated that FP008 significantly reduces PD-1 antibody-mediated CD8⁺ T-cell exhaustion and exhibits potent anti-tumor efficacy. Key findings include: 

– Enhanced infiltration of CD8⁺ T-cells into tumors;
– Reduced terminal exhaustion differentiation of CD8⁺ T-cells;
– Increased secretion of IFN-γ and GZMB in terminally exhausted CD8⁺ T-cells.

Additionally, FP008 showed favorable safety and pharmacokinetic (PK) profiles in cynomolgus monkey studies, supporting its clinical potential. FP008 has received Investigational New Drug (IND) approval from both the U.S. FDA and China’s NMPA.

The multi-center Phase I trial in China is led by Zhejiang Cancer Hospital, with two additional sites participating. Professor Zhengbo Song, Principal Investigator at Zhejiang Cancer Hospital, stated: “FP008 offers a promising therapeutic strategy for solid tumor patients resistant to anti-PD-1 antibodies. Its unique mechanism could address a critical unmet clinical need in immuno-oncology. We look forward to further evaluating its safety and efficacy in the clinic.” 

About FP008

FP008 is a novel anti-PD-1×IL-10M fusion protein with a unique mechanism of action (MOA) and therapeutic potential for anti-PD-1 naïve or resistant patients. IL-10 monomer (IL-10M) engineering significantly reduces its hematologic toxicity, while the anti-PD-1 antibody enhances IL-10M activity by PD-1 targeted enrichment and cis-activation. This breakthrough offers a new treatment choice for patients who have limited options and could potentially transform the treatment paradigm for solid tumors. Fapon Biopharma is actively seeking strategic partnerships with biopharmaceutical companies worldwide to co-develop FP008 through clinical trials or further commercialization. 

About Fapon Biopharma 

Fapon Biopharma specializes in discovering and developing biologics for cancer treatment, autoimmune diseases and other diseases where there are unmet medical needs. Leveraging cutting-edge technologies, we have built advanced drug discovery platforms, including an antibody discovery platform based on the globally leading mammalian cell display technology, a platform for generating IL-10M fusion proteins, a TCE platform based on cross-species CD3 nanobody of human and monkey. With a differentiated pipeline of leading drug candidates, we have established capabilities that cover the entire drug development process from drug discovery, preclinical research, Chemistry, Manufacturing and Controls (CMC) to early clinical development. Committed to innovation, we strive to deliver safer, more efficacious, affordable, and accessible biologics for everyone.

For more information about FP008 and partnership opportunities, please visit our website (https://en.faponbiopharma.com/) or contact our Business Development team.
Max Wang: max.wang@fapon.com;
Liyan Gao: liyan.gao@fapon.com

Vietnam Allows All Women to Access Fertility Treatments by Choice

Vietnam Allows All Women to Access Fertility Treatments by Choice
This image is used only for representational purpose (photo credit: Pexels)

Starting on 1 October, Vietnam will allow all women to access assisted reproductive technologies (ART), including egg freezing and in vitro fertilization (IVF), based on their personal choice.

Sharjah Records $7.3B Real Estate Transactions in First Half of 2025, up 48.1%

PEOPLE FROM 109 COUNTRIES INVEST IN SHARJAH IN H1 – INDIAN, SYRIAN INVESTORS LEAD

SHARJAH, UAE, Aug. 5, 2025 /PRNewswire/ — Real estate transactions in the emirate of Sharjah surged to $7.3 billion in the first half of 2025, up 48.1% from $4.9 billion in the same period last year, according to Sharjah Real Estate Registration Department.

The number of transactions rose to over 48,000, a 3.3% increase from 2024. Investors from 109 nationalities participated, reflecting Sharjah’s growing appeal as a global real estate destination, driven by diverse property offerings, advanced infrastructure, and rising investor confidence. 

Emirati investors led investments with $3.3 billion in transactions. Other Gulf nationals added $0.3 billion, bringing total GCC investments to $3.6 billion.

India recorded a significant increase with nearly $1 billion in investments. Among Arab nationalities, Syrian investors recorded the highest value at $405 million, followed by investors from Pakistan, Jordan, Iraq, and Egypt.

Britain Leads European Investments
The United Kingdom ranked ninth overall, leading European investors with $123 million in transactions. It was followed by France, Germany, the Netherlands, and Sweden, along with Italy, Ukraine, Greece, Switzerland, Ireland, and Belgium. The US, Canada, and Australia collectively invested $191 million.

Abdulaziz Al Shamsi, Director General of the Sharjah Real Estate Registration Department, credited the government’s commitment to a modern legislative framework for strong performance.

“Current indicators are promising for a prosperous future in the real estate sector”, he said. “We are also continuing our efforts to reinforce Sharjah’s position as a leading economic and real estate hub both regionally and globally.”

The full article can be found here.

–  Image is available at AP –

Hussain Al Mulla
Media Relations Executive – Sharjah Government Media Bureau
+971563980067
Hussain.almulla@sgmb.ae

CoinW Unveils Upgraded Fee Structure and Reward Ecosystem to Boost Crypto Utility and Earnings

HONG KONG, Aug. 5, 2025 /PRNewswire/ — CoinW, a global leading cryptocurrency asset trading platform, has unveiled a major upgrade to its spot trading fee structure, alongside additional user benefits and global payment perks. This initiative marks a significant step toward building a trade-to-earn-driven asset ecosystem, offering users more flexibility, efficiency, and profitability.

Spot Fee System Fully Upgraded
Spot Fee System Fully Upgraded

Lower Fees, More Benefits 

The upgraded spot trading fee structure introduces a nine-level system (Lv1–Lv9),  based on either a user’s 30-day trading volume or average daily asset holdings. No applications or manual reviews are needed—tiers are updated daily.

With maker and taker fees dropping as low as 0.020% and 0.030%, CoinW’s rates are well below industry averages—offering strong value without compromising liquidity or capital efficiency. This streamlined model lowers entry barriers for new users while better rewarding active traders and long-term holders alike.

“The update isn’t simply a fee adjustment—it’s a pivotal step in advancing the CoinW asset experience,” said Nassar Achkar, CoinW’s Chief Strategy Officer. “We’re building an inclusive crypto financial ecosystem where users can grow their assets and spend them globally, all within one platform. This reflects our commitment to both technological progress and the long-term promise of democratized crypto finance.”

Seamless Global Payments with CoinW Card

As part of the upgrade, CoinW is also rolling out the CoinW Card—a global crypto payment solution that links your digital assets to everyday spending.

Users can apply for a virtual or physical SGD-denominated card and pay with USDT directly—no need for manual withdrawals. Highlights include:

  • Free virtual card issuance with zero monthly fees
  • Physical cards support global ATM withdrawals with single transaction limits up to $20,000
  • Support for online and offline purchases worldwide
  • Up to 50% off physical card fees during the launch period

More than a payment tool, CoinW Card connects digital assets to real-world spending, advancing crypto adoption worldwide. Whether shopping online or withdrawing cash abroad, users enjoy a truly borderless payment experience.

As part of the Fast-Track Access Program, eligible users can unlock CoinW Card privileges, tiered fee discounts, and extra incentive coupons—all in one go.

Limited-Time Campaigns to Celebrate the Upgrade

To mark this milestone, CoinW will run three user-centric campaigns from August 4 to August 31, providing easier access to discounted trading fees, enhanced reward opportunities, and exclusive benefits:

  • Tier Access at Half Threshold: Trade or hold 50% of usual requirements to enjoy tiered fee discounts for 30 days.
  • 7-Day Fee Trial for New Users: New or migrating users can submit proof of trading or holdings from other platforms to receive Lv3 fee rates (Maker 0.070%, Taker 0.075%) for 7 days.
  • 100% Win Mystery Box Draw: Complete daily tasks for up to 4 chances to win prizes such as discounted fee cards, CoinW Cards, reward coupons, and popular tokens like SOL and PEPE.

These campaigns make CoinW’s asset ecosystem more accessible, providing users with opportunities to engage and transact more efficiently.

By lowering fees, enhancing trading conditions, and enabling real-world spending options, CoinW continues to expand the practical use of cryptocurrencies—turning digital assets into everyday lifestyle tools and making crypto finance more accessible and user-friendly for everyone.

About CoinW

Founded in 2017, CoinW has grown into one of the world’s leading cryptocurrency asset trading platforms, serving a vast and diverse global user base. The platform offers intelligent trading services, with a daily trading volume exceeding $5 billion and a consistent top 4 ranking in CoinMarketCap’s futures markets. With over 10 million registered users, CoinW is deeply committed to advancing wealth creation and blockchain innovation, continually enhancing its product ecosystem with innovations. Since 2022, CoinW has significantly expanded its global brand presence through international sports sponsorships, including a high-profile partnership with football legend Andrea Pirlo. In addition to its commercial growth, CoinW is actively engaged in corporate social responsibility — from donating supplies to orphanages in Africa to supporting animal welfare in Taiwan. Looking ahead, CoinW aims to promote financial inclusion on a global scale, continue leading the cryptocurrency sector, and accelerate the adoption of blockchain technology and digital assets worldwide. To learn more about CoinW, you can visit the website, and follow CoinW’s X Account, and Telegram Group.

Sunshine Lake Pharma Co., Ltd. (06887.HK) Completes Listing, Market Capitalisation Expected to Rapidly Surpass RMB 50 Billion

GUANGZHOU, China, Aug. 5, 2025 /PRNewswire/ — Sunshine Lake Pharma Co., Ltd. (06887.HK) announced that the company will officially list on the Hong Kong Stock Exchange on August 7th. Through this integration, the company has effectively combined its expertise in drug R&D with the mature nationwide sales network resources of Sunshine Lake Pharma Co., Ltd. This forms an R&D-manufacturing-sales closed loop to accelerate global operations, thereby driving value reshaping and laying a more solid foundation for future sustainable development, including international expansion.

This year, propelled by policy support, increased capital investment, and the industry trend of innovative drug globalization, the company’s innovative drug segment has demonstrated significant value.

Market analysis indicates that the company’s current commercial pipeline products show considerable commercial potential. The anti-infective pediatric line represented by oseltamivir phosphate, the new drug line represented by hepatitis C, the chronic disease line represented by diabetes, and the centralized drug procurement and new retail lines are expected to bring an annual sales peak of RMB 20 billion.

Innovation and R&D are the core driving force for the long-term development of enterprises. First, we have a rich pipeline of high-potential innovative drugs, with numerous successful results: 3 original innovative drugs have been launched, 49 Class 1 innovative drugs are under development, one of which is about to be launched, and 10 have entered Phase II and III clinical trials; Second, our Sunshine Lake Pharma has many star products. Yinfenidone is the first domestically produced new drug to enter Phase III clinical trials for the treatment of IPF. It also has the potential to expand its indications to include PF-ILD and liver fibrosis. It has the potential to become a best-in-class product in the global fibrosis field. Compared with previous cases, it is a potential blockbuster BD transaction product; Insulin glargine injection has been applied for marketing approval in the United States. Insulin Aspart is about to begin overseas clinical trials; Third, there are dozens of reserve projects with overseas BD potential, many of which have licensing values exceeding US$1 billion.

Chunghwa Telecom Reports Un-Audited Consolidated Operating Results for the Second Quarter of 2025

TAIPEI, Aug. 5, 2025 /PRNewswire/ — Chunghwa Telecom Co., Ltd. (TAIEX: 2412, NYSE: CHT) (“Chunghwa” or “the Company”) today reported its un-audited operating results for the second quarter of 2025. All figures were prepared in accordance with Taiwan-International Financial Reporting Standards (“T-IFRSs”) on a consolidated basis.

(Comparisons throughout the press release, unless otherwise stated, are made with regard to the prior year period.)

Second Quarter 2025 Financial Highlights

  • Total revenue increased by 4.8% to NT$ 56.73 billion.
  • Consumer Business Group revenue increased by 1.4% to NT$ 34.07 billion.
  • Enterprise Business Group revenue increased by 12.4% to NT$ 18.98 billion.
  • International Business Group revenue decreased by 16.8% to NT$ 2.20 billion.
  • Total operating costs and expenses increased by 4.8% to NT$ 44.19 billion.
  • Operating income increased by 5.2% to NT$ 12.54 billion.
  • EBITDA increased by 3.5% to NT$ 22.58 billion.
  • Net income attributable to stockholders of the parent increased by 3.5% to NT$ 10.17 billion.
  • Basic earnings per share (EPS) was NT$1.31.
  • Total revenue, operating income, net income attributable to stockholders of the parent and EPS all exceeded the upper end of our proposed guidance.

“We’re proud to deliver another outstanding quarter, with results exceeding the upper end of our guidance across revenue, operating income, net income attributable to stockholders of the parent, and EPS,” stated Mr. Chih-Cheng Chien, Chairman and CEO of Chunghwa Telecom. “Second quarter revenue reached a ten-year high for the same period, driven by robust growth in our core telecom services and enterprise ICT business. Despite ongoing global economic uncertainty, evolving geopolitical risks, and the rapid pace of digital transformation, our performance underscores the strength of our business model, the agility of our organization, and our ability to capitalize on emerging opportunities.”

“Chunghwa continued to lead the mobile market, achieving record highs in both subscriber and revenue share,” said Mr. Rong-Shy Lin, President of Chunghwa Telecom. “In fixed broadband, higher-speed plan adoption and bundled service offerings drove further ARPU expansion. We also saw broad-based growth across consumer allocation services, including multi-play packages, video content, and cybersecurity solutions. Our Enterprise Business Group delivered a standout quarter, with total ICT revenue up 37% year-over-year, fueled by strong demand for IDC, cloud, AIoT, and 5G private networks. While our International Business Group faced temporary headwinds due to project timing, demand in Southeast Asia remained solid with new ICT contracts secured in Vietnam and Singapore. We remain focused on expanding our presence in high-growth overseas markets.”

“Looking ahead, we remain confident in our strategy to position Chunghwa as a leading digital enabler in the AI era,” added Mr. Lin. “From launching major submarine cable systems and scaling LEO satellite connectivity, to being upgraded to MSCI ESG ‘AAA’ and receiving prestigious data center awards, we are building a future-ready infrastructure that ensures resilient, secure, and intelligent connectivity—both in Taiwan and globally. These advancements reinforce our industry leadership and create sustainable, long-term value for our shareholders.”

Revenue
Chunghwa Telecom’s total revenues for the second quarter of 2025 increased by 4.8% to NT$ 56.73 billion.

Consumer Business Group’s revenue for the second quarter of 2025 increased by 1.4% YoY to NT$ 34.07 billion, with its income before tax increased 4.8% YoY. The remarkable performance was mainly driven by steady growth in both mobile and fixed broadband ARPU. In addition to stable performance of core service revenues, CBG also benefited from higher smartphone sales, as consumers accelerated purchases in anticipation of potential tariff fluctuations.

Enterprise Business Group’s revenue for the second quarter of 2025 increased 12.4% YoY to NT$ 18.98 billion, mainly driven by our robust growth in ICT business, which saw a 37% year-over-year increase in revenue, fueled by the strong performance of our emerging services. As a result, EBG reported a robust 5.4% increase in income before tax during the quarter.

International Business Group’s revenue for the second quarter of 2025 decreased by 16.8% to NT$ 2.20 billion, while its income before tax decreased 11.9% YoY. The decline was mainly due to reduced demand for international fixed voice services and softening international roaming revenues.

Operating Costs and Expenses 
Total operating costs and expenses for the second quarter of 2025 increased by 4.8% to NT$ 44.19 billion, mainly due to higher manpower cost and the growing ICT business.

Operating Income and Net Income
Operating income for the second quarter of 2025 increased by 5.2% to NT$ 12.54 billion. The operating margin was 22.1%, as compared to 22.0% in the same period of 2024. Net income attributable to stockholders of the parent increased by 3.5% to NT$ 10.17 billion. Basic earnings per share was NT$1.31.

Cash Flow and EBITDA
Cash flow from operating activities, as of June 30th, 2025, decreased by 0.2% year over year to NT$ 29.16 billion.

Cash and cash equivalents, as of June 30th, 2025, decreased by 7.1% to NT$ 35.05 billion as compared to that as of June 30th, 2024.

EBITDA for the second quarter of 2025 was NT$ 22.58 billion, increasing by 3.5% year over year. EBITDA margin was 39.80%, as compared to 40.31% in the same period of 2024.

Business Highlights

Mobile
As of June 30th, 2025, Chunghwa Telecom had 13.13 million mobile subscribers, representing a 2.2% year-over-year decrease. In the second quarter, total mobile service revenue increased by 2.0% to NT$ 17.06 billion, while mobile post-paid ARPU excluding IoT SIMs maintained stable and flat year over year at NT$ 556.

Fixed Broadband/HiNet
As of June 30th, 2025, the number of broadband subscribers slightly increased by 0.7% to 4.44 million. The number of HiNet broadband subscribers increased by 1.3% to 3.77 million. In the second quarter, total fixed broadband revenue grew 1.8% year over year to NT$ 11.59 billion, while ARPU increased 1.9% to NT$ 804.

Fixed line
As of June 30th, 2025, the number of fixed-line subscribers was 8.77 million.

Financial Statements
Financial statements and additional operational data can be found on the Company’s website at http://www.cht.com.tw/en/home/cht/investors/financials/quarterly-earnings

NOTE CONCERNING FORWARD-LOOKING STATEMENTS
This press release contains forward-looking statements. These statements constitute “forward-looking” statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates” and similar statements. Statements that are not historical facts, including statements about Chunghwa’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. A number of important factors could cause actual results to differ materially from those contained in any forward-looking statement. Investors are cautioned that actual events and results could differ materially from those statements as a result of a number of factors including, but not limited to the risks outlined in Chunghwa’s filings with the U.S. Securities and Exchange Commission on Forms F-1, F-3, 6-K and 20-F, in each case as amended. The forward-looking statements in this press release reflect the current belief of Chunghwa as of the date of this press release and Chunghwa undertakes no obligation to update these forward-looking statements for events or circumstances that occur subsequent to such date, except as required under applicable law.

This press release is not an offer of securities for sale in the United States. Securities may not be offered or sold in the United States absent registration or an exemption from registration. Any public offering of securities to be made in the United States will be made by means of a prospectus that may be obtained from the issuer or selling security holder and that will contain detailed information about the company and management, as well as financial statements.

NON-GAAP FINANCIAL MEASURES
To supplement the Company’s consolidated financial statements presented in accordance with International Financial Reporting Standards pursuant to the requirements of the Financial Supervisory Commission, or T-IFRSs, Chunghwa Telecom also provides EBITDA, which is a “non-GAAP financial measure”. EBITDA is defined as consolidated net income (loss) excluding (i) depreciation and amortization, (ii) total net comprehensive financing cost (which is comprised of net interest expense, exchange gain or loss, monetary position gain or loss and other financing costs and derivative transactions), (iii) other income, net, (iv) income tax, (v) (income) loss from discontinued operations.

In managing the Company’s business, Chunghwa Telecom relies on EBITDA as a means of assessing its operating performance because it excludes the effect of (i) depreciation and amortization, which represents a non-cash charge to earnings, (ii) certain financing costs, which are significantly affected by external factors, including interest rates, foreign currency exchange rates and inflation rates, which have little or no bearing on our operating performance, (iii) income tax (iv) other expenses or income not related to the operation of the business. 

CAUTIONS ON USE OF NON-GAAP FINANCIAL MEASURES
In addition to the consolidated financial results prepared under T-IFRSs, Chunghwa Telecom also provide non-GAAP financial measures, including “EBITDA”. The Company believes that the non-GAAP financial measures provide investors with another method for assessing its operating results in a manner that is focused on the performance of its ongoing operations.

Chunghwa Telecom’s management believes investors will benefit from greater transparency in referring to these non-GAAP financial measures when assessing the Company’s operating results, as well as when forecasting and analyzing future periods. However, the Company recognizes that:

  • these non-GAAP financial measures are limited in their usefulness and should be considered only as a supplement to the Company’s T-IFRSs financial measures;
  • these non-GAAP financial measures should not be considered in isolation from, or as a substitute for, the Company’s T-IFRSs financial measures;
  • these non-GAAP financial measures should not be considered to be superior to the Company’s T-IFRSs financial measures; and
  • these non-GAAP financial measures were not prepared in accordance with T-IFRSs and investors should not assume that the non-GAAP financial measures presented in this earnings release were prepared under a comprehensive set of rules or principle.

Further, these non-GAAP financial measures may be unique to Chunghwa Telecom, as they may be different from non-GAAP financial measures used by other companies. As such, this presentation of non-GAAP financial measures may not enhance the comparability of the Company’s results to the results of other companies. Readers are cautioned not to view non-GAAP results as a substitute for results under T-IFRSs, or as being comparable to results reported or forecasted by other companies.

About Chunghwa Telecom
Chunghwa Telecom (TAIEX 2412, NYSE: CHT) (“Chunghwa” or “the Company”) is Taiwan’s largest integrated telecommunications services company that provides fixed-line, mobile, broadband, and internet services. The Company also provides information and communication technology services to corporate customers with its big data, information security, cloud computing and IDC capabilities, and is expanding its business into innovative technology services such as IoT, AI, etc. Chunghwa has been actively and continuously implemented environmental, social and governance (ESG) initiatives with the goal to achieve sustainability and has won numerous international and domestic awards and recognitions for its ESG commitments and best practices. For more information, please visit our website at www.cht.com.tw

Contact: Angela Tsai
Phone: +886 2 2344 5488
Email: chtir@cht.com.tw

Clarisound rolls out mobile and tele-audiology services across Malaysia


KUALA LUMPUR, MALAYSIA – Media OutReach Newswire – 5 August 2025 – Clarisound is revolutionizing hearing care delivery by bringing professional audiology services directly to Malaysians through online tests, telecare appointments, and digital tools—extending expert support to homes, offices, and virtually anywhere.

Remote Hearing Healthcare

The company’s Telecare service supports existing Clarisound customers who’ve completed in-person hearing tests, otoscopy, and device fitting. These foundational steps require face-to-face interaction for accuracy. Once established, Telecare bridges the gap between visits, delivering professional expertise wherever customers are.

Recognizing widespread reluctance to address hearing issues, Clarisound offers online hearing tests accessible via smartphone or computer. This discreet, minutes-long assessment provides an entry point for those uncertain about their hearing health or hesitant to seek clinical care.

Technology-Driven Accessibility

Telecare services complement in-store consultations through video appointments with qualified audiologists who evaluate, adjust, and troubleshoot remotely. This approach reduces travel time and costs while ensuring continuity for those with mobility challenges or time constraints.

“Telecare isn’t a replacement, but a smart extension of personalized hearing care,” explains Kieran McCarry, Clarisound’s founder. “In-person visits remain essential for comprehensive assessments—hearing tests, ear examinations, real-ear measurements, and initial fittings. However, Telecare maintains connection between appointments, supporting aural rehabilitation with remote adjustments that fit seamlessly into daily life. This proactive approach enhances comfort and drives better long-term outcomes.”

Bridging Technology and Health

Clarisound leverages growing interest in devices like Apple AirPods Pro2 as conversation starters about hearing health. While not medical-grade substitutes, features like “Conversation Boost” increase sound quality awareness, prompting users to seek professional advice.

Regional Impact

This model proves particularly impactful where hearing health awareness is developing. By eliminating traditional barriers—geographic distance, stigma, and clinical accessibility—Clarisound empowers individuals to address hearing health earlier and more confidently.

The integration of mobile technology, online testing, and professional telecare positions Clarisound as a Malaysian healthcare leader. Rather than treating hearing loss as niche, the company reframes it as central to everyday health. With every mobile test, teleconsultation, or hearing aid fitted, Clarisound brings hearing care out of clinical settings into daily life, where it belongs.

Hashtag: #Clarisound

The issuer is solely responsible for the content of this announcement.

About Clarisound

Clarisound is a leading hearing care provider delivering accessible, expert audiology services. Focusing on user experience and early intervention, the company combines advanced technology with professional care to support hearing health across Malaysia.

1 in Every 25 Singaporeans Visiting Japan Chooses MIMARU — Popular Apartment Hotel Brand to Propose “Learn-and-play Family Holidays” for First Time

TOKYO, Aug. 5, 2025 /PRNewswire/ — Cosmos Hotel Management Co., Ltd., operator of Japan’s leading apartment hotel brand MIMARU, will exhibit at NATAS Holidays 2025 to be held from August 15 to 17 at Singapore EXPO. For the first time, MIMARU is proposing a new kind of family holiday for Singaporean travelers this autumn and winter — hands-on trips to Japan that combine STEAM-themed learning experiences with the beauty of Japan’s seasonal landscapes and traditional cultural activities.

Photo1: https://cdn.kyodonewsprwire.jp/prwfile/release/M107482/202507292874/_prw_PI1fl_eswOKrP0.png 

What Makes MIMARU Favorite for Singaporean Families

-Over 90% of guests are international families.

-Spacious rooms from about 40 to 100 square meters, ideal for families and groups.

-All rooms equipped with kitchens and living/dining areas.

-Friendly, English-speaking staff from 38 countries and regions.

-27 locations across Tokyo, Kyoto and Osaka, offering apartment-style stays in convenient city settings.

-Convenient access from Singapore: direct flights to Tokyo (about seven hours) and Osaka (about six hours 40 minutes), with most MIMARU locations reachable within an hour from the airport.

This explains why one in every 25 Singaporean visitors to Japan stayed at MIMARU in 2024. (Based on MIMARU’s 2024 guest data)

For more information, visit: https://mimaruhotels.com/en/ 

Photo2: https://cdn.kyodonewsprwire.jp/prwfile/release/M107482/202507292874/_prw_PI2fl_4TP4u9PC.png 

Experience Japan Differently: MIMARU’s Family Learning Holiday Ideas

1.Explore Science & Pop Culture through Hands-on Activities

Discover digital art at teamLab Planets, futuristic gadgets in Akihabara, and science museums in Osaka — ideal destinations for STEAM education experiences that transcend language barriers.

2.Enjoy Japan’s Beautiful Autumn & Winter Landscapes

Collect colorful leaves, visit temples, and experience the charm of Japan’s four seasons during cool, crisp walks through city streets and nature.

3.Join Traditional Japanese Festivities

Try mochi-making, help craft New Year’s decorations, and experience heart-warming local traditions that offer unique cultural insights for families.

“At MIMARU, we welcome many families from Singapore throughout the year. We’re happy to propose this new travel idea combining STEAM education and cultural experiences, based on what we’ve seen many children enjoy.” — MIMARU Staff

MIMARU supports children’s growth and quality family time through unique travel experiences in Japan.

For more information, visit: https://mimaruhotels.com/en/news/family-friendly-japan-with-mimaru/ 

teamLab, Rapidly Rotating Bouncing Spheres in the Caterpillar House (C) teamLab

All images: https://kyodonewsprwire.jp/release/202507292874?p=images